Insight Genetics and National Cancer Institute Collaborate to Develop New Technologies for Clinical Trials

News   Apr 02, 2013

 
Insight Genetics and National Cancer Institute Collaborate to Develop New Technologies for Clinical Trials
 
 
 
 

RELATED ARTICLES

Ingestible Drug-Delivery Materials May Improve Patient Treatment Compliance

News

Hydrogel-based capsules could expand and reside in the GI tract for days, slowly releasing medication.

READ MORE

Nanoparticle Delivery of Curcumin Induces Tumor Cell Death

News

Attaching curcumin, a component of the common spice turmeric, to nanoparticles can be used to target and destroy treatment-resistant neuroblastoma tumor cells

READ MORE

Acquisition Sees Agilent Gain Powerful NGS IP Portfolio

News

Agilent Technologies announces its acquisition of the molecular and sample barcoding portfolios of Population Genetics Technologies.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE